Cervomed reports fourth quarter and full year 2023 financial results and provides corporate updates

- announced private placement of up to $149.4 million led by ra capital management with participation from armistice capital, special situations funds and soleus capital; pro forma cash and cash equivalents from upfront proceeds expected to provide runway through the end of 2025
CRVO Ratings Summary
CRVO Quant Ranking